ID Source | ID |
---|---|
PubMed CID | 15575 |
CHEMBL ID | 401410 |
SCHEMBL ID | 145757 |
MeSH ID | M0167016 |
Synonym |
---|
nitric acid, isopropyl ester |
nsc88934 |
1712-64-7 |
nsc-88934 |
wln: wnoy1&1 |
isopropyl nitrate [un1222] [flammable liquid] |
isopropylester kyseliny dusicne |
unii-upe48e4uj4 |
upe48e4uj4 , |
isopropylester kyseliny dusicne [czech] |
einecs 216-983-6 |
un1222 |
brn 1701405 |
nsc 88934 |
nitric acid, 1-methylethyl ester |
isopropyl nitrate |
2-nitrooxy-propane |
CHEMBL401410 |
propan-2-yl nitrate |
inchi=1/c3h7no3/c1-3(2)7-4(5)6/h3h,1-2h3 |
gapfwgoshocnbm-uhfffaoysa- |
A811312 |
nitric acid propan-2-yl ester |
AKOS015918342 |
FT-0633789 |
AB00827 |
SCHEMBL145757 |
iso-propylnitrate |
isopropylnitrate |
iso- propylnitrate |
DTXSID5061908 |
(ch3)2chono2 |
un 1222 |
mfcd00007041 |
2-propyl nitrate |
nitric acid isopropyl ester |
J-010705 |
Q905731 |
BS-42208 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID309710 | Vasodilatory effect in pig pulmonary artery assessed as inhibition of PGF2-alpha-induced contraction | 2007 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 17, Issue:21 | NO donors. Part 16: investigations on structure-activity relationships of organic mononitrates reveal 2-nitrooxyethylammoniumnitrate as a high potent vasodilator. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (43.08) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 2 (40.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 3 (60.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |